Clinical Trial Update: A Safety and Efficacy Trial of Multiple Dosing Regimens of ABT-719 for the Prevention of Acute Kidney Injury in Subjects Undergoing High Risk Surgery [Phase 2]

View source ↗

Summary

Phase 2 safety and efficacy trial of ABT-719 for preventing acute kidney injury in high-risk surgery patients has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Injury

Drugs mentioned

• ABT-719

Snippet

Sponsor: AbbVie | Conditions: Cardiothoracic Surgery, Vascular Surgery | Phase 2 | Status: TERMINATED